Atossa Genetics Inc. (ATOS): Price and Financial Metrics

Atossa Genetics Inc. (ATOS): $1.20

0.08 (-6.25%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ATOS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#173 of 332

in industry

ATOS Price/Volume Stats

Current price $1.20 52-week high $2.31
Prev. close $1.28 52-week low $0.70
Day low $1.19 Volume 1,328,300
Day high $1.26 Avg. volume 1,075,256
50-day MA $1.43 Dividend yield N/A
200-day MA $1.38 Market Cap 150.96M

ATOS Stock Price Chart Interactive Chart >


Atossa Genetics Inc. (ATOS) Company Bio


Atossa Therapeutics, Inc. develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions in the United States. The company's lead program is the development of Endoxifen, an active metabolite of tamoxifen which is in Phase II studies to treat and prevent breast cancer. It is also developing intraductal microcatheter technology to target the delivery of therapies, including fulvestrant, immunotherapies, and Chimeric Antigen Receptor T-cell therapies, directly to the site of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2009 and is headquartered in Seattle, Washington.


ATOS Latest News Stream


Event/Time News Detail
Loading, please wait...

ATOS Latest Social Stream


Loading social stream, please wait...

View Full ATOS Social Stream

ATOS Price Returns

1-mo -20.00%
3-mo -15.49%
6-mo -17.81%
1-year 56.11%
3-year -48.94%
5-year -13.04%
YTD 36.36%
2023 66.51%
2022 -66.97%
2021 68.42%
2020 -39.49%
2019 53.92%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!